ACG: No Cancer Risk With Biologic in Crohn’s (CME/CE)

WASHINGTON (MedPage Today) — Patients with Crohn’s disease who are taking infliximab don’t have a higher cancer rate than those on other therapies, a researcher said here.

Post a Comment

Comments are closed.